The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence and clinical correlates of vulnerable status using the Vulnerable Elders Survey 13 (VES-13) in newly diagnosed adult non-Hodgkin lymphoma (NHL) patients: A LEO cross-sectional analysis.
 
Angelo Fama
No Relationships to Disclose
 
Peter Martin
Honoraria - Janssen
Consulting or Advisory Role - Acerta Pharma; Bayer; Celgene; Genentech/Roche; Gilead Sciences; Janssen; Kite, a Gilead company; Novartis; Pharmacyclics; Seagen; Verastem
Research Funding - Teva (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Carla Casulo
Consulting or Advisory Role - Infinity Pharmaceuticals
Research Funding - Celgene (Inst)
 
Loretta J. Nastoupil
Honoraria - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Novartis; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; TG Therapeutics
 
Carrie A. Thompson
Research Funding - Kite, a Gilead company
 
Brian K. Link
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche
 
Izidore S. Lossos
No Relationships to Disclose
 
Brad Kahl
No Relationships to Disclose
 
Matthew Maurer
No Relationships to Disclose
 
Cristine Allmer
No Relationships to Disclose
 
David L. Jaye
No Relationships to Disclose
 
Andew L. Feldman
Consulting or Advisory Role - Infinity Pharmaceuticals
Patents, Royalties, Other Intellectual Property - ALF is an inventor of technology for which Mayo Clinic holds an unlicensed patent or has submitted a patent application. (Inst)
 
Susan L. Slager
No Relationships to Disclose
 
Jonathan W. Friedberg
Consulting or Advisory Role - Bayer
Research Funding - Kite, a Gilead company (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Roche
 
Thomas Matthew Habermann
No Relationships to Disclose
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Denovo Biopharma; Gilead Sciences; Karyopharm Therapeutics; OptumRx; Pharmacyclics/Janssen; Seagen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
James Robert Cerhan
No Relationships to Disclose